(N.J., filed October 5, 2020): Urging the New Jersey Supreme Court to review a lower court’s incorrect application of the state’s expert evidence standard. Arguing that the Court needs to overturn the decision to reinforce the message of its opinion in In re Accutane. The opinion, if not reversed, will leave trial courts with great uncertainty as to the gatekeeping role in New Jersey’s many drug, tort and product lawsuits.